NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The governor’s expected sign-off comes after heated negotiations over how closely New York’s RAISE Act should mirror California’s pioneering law.Read More